{"id":"W4200186760","doi":"10.1016/s1470-2045(21)00719-1","title":"Radiographic progression-free survival in the ACIS trial for prostate cancer","year":2021,"lang":"en","type":"letter","venue":"The Lancet Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Prednisone; Abiraterone acetate; Placebo; Clinical endpoint; Prostate cancer; Internal medicine; Enzalutamide; Oncology; Progression-free survival; Surgery; Randomized controlled trial; Cancer; Androgen deprivation therapy; Pathology; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007003361,0.0005409074,0.002169074,0.0004603581,0.001571849,0.002163327,0.001281678,0.01923925,0.008640983],"category_scores_gemma":[0.0237188,0.0004909952,0.001225672,0.0007354172,0.0013044,0.002091626,0.0008642544,0.01650319,0.003667719],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003309556,"about_ca_system_score_gemma":0.003718257,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005694224,"about_ca_topic_score_gemma":0.01479382,"domain_scores_codex":[0.9947457,0.003107538,0.000361839,0.0002907077,0.0009018273,0.0005924093],"domain_scores_gemma":[0.9887262,0.007667136,0.0007417058,0.0002744662,0.0007302074,0.001860348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.007245108,0.0001638152,0.002672175,0.0002582405,0.0001339976,0.0006461788,0.00009741914,0.0002730252,0.0003507553,0.003776709,0.9337195,0.05066299],"study_design_scores_gemma":[0.01588361,0.00270169,0.02080931,0.001247819,0.0006466359,0.001706548,0.0004417125,0.002630838,0.001035817,0.02884089,0.9238729,0.0001822029],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.00398246,0.008781449,0.00010607,0.9526236,0.0200469,0.00004411412,0.0008387737,0.00004400039,0.01353275],"genre_scores_gemma":[0.0400884,0.003885114,0.0002722208,0.8828332,0.05701883,0.0002184147,0.0005849939,0.00005669985,0.01504208],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01923925,"threshold_uncertainty_score":0.03703779,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1184317975830802,"score_gpt":0.4310193453638538,"score_spread":0.3125875477807736,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}